ARK Investment Management LLC 13D and 13G filings for Intellia Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-29 4:00 pm Purchase | 2023-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 11,412,449 12.740% | 1,991,667 (+21.14%) | Filing |
| 2023-02-10 12:41 pm Purchase | 2022-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 9,420,782 11.200% | 1,503,900 (+19.00%) | Filing |
| 2022-02-09 2:38 pm Purchase | 2021-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 7,916,882 10.640% | 274,430 (+3.59%) | Filing |
| 2021-11-26 3:23 pm Sale | 2021-10-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 7,642,452 10.400% | -3,549,218 (-31.71%) | Filing |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA | ARK Investment Management LLC | 11,191,670 17.400% | 2,450,238 (+28.03%) | Filing |